Swiss National Bank
IMUX icon

Swiss National Bank’s Immunic IMUX Stock Holding History

Swiss National Bank’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-49
Closed -$80K – 2650
2015
Q3 		$80K Hold
49
– – ﹤0.01% 2558
2015
Q2 		$417K Hold
49
– – ﹤0.01% 2323
2015
Q1 		$494K Buy
49
+13
+36% +$119K ﹤0.01% 2179
2014
Q4 		$354K Buy
+36
New +$277K ﹤0.01% 2347

Other funds holding IMUX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RIM
RS Investment Management San Francisco, California $9.73B AUM 3.24% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TP
Truvvo Partners New York $5.22M AUM 13.74% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SRF
Silver Rock Financial Los Angeles, California $46.4M AUM 13.94% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Swiss National Bank's IMUX Position: Q4 2015 in Review

Swiss National Bank sold out of Immunic (IMUX) in Q4 2015, closing a stake of 49 shares — an estimated $80K sold.

Swiss National Bank first reported a position in IMUX in Q4 2014 and held it in 4 quarters. The position peaked at $494K in Q1 2015. 54 funds tracked by Wall St. Rank hold IMUX as of Q4 2015.

  • Swiss National Bank reported no remaining Immunic position as of Q4 2015 after selling out during the quarter.
  • Swiss National Bank sold 49 Immunic shares in Q4 2015, an estimated $80K.
  • Swiss National Bank first reported a position in Immunic in Q4 2014 and held it in 4 quarters.
  • Swiss National Bank's Immunic position peaked at $494K in Q1 2015.
  • 54 funds tracked by Wall St. Rank held Immunic as of Q4 2015.

Based on Swiss National Bank's 13F filing for Q4 2015, filed 3 Feb 2016.